鲜红斑痣发病及进展机制研究进展

doi:10.35541/cjd.20240052

Abstract

Abstract: 【Abstract】 Port-wine stains （PWS） are vascular malformations characterized by dilated capillaries and postcapillary venules in the skin. Clinically, they mainly manifest as pink or red irregular patches, most of which may become thickened, darkened in color, or even develop into nodules over age, making treatment more challenging. The mechanisms underlying the development and progression of PWS are not very clear, and may be related to heredity, gene mutations, abnormal ratios of blood vessels to nerves, etc. This review summarizes research progress in the mechanisms underlying the development and progression of PWS, so as to provide a theoretical basis for their treatment.

Key words: Port-wine stain, Vascular malformations, Therapy, Pathogenesis, Disease progression

Chen Haotian, Liu Lian, Zhang Ting, Liu Qingfeng, Li Xiaoxue, Diao Ping, Jiang Xian. Port-wine stains: mechanisms underlying the development and progression[J]. Chinese Journal of Dermatology, 2024, 57(7): 661-664.doi:10.35541/cjd.20240052

References ［43］

［1］	Escobar K, Pandher K, Jahnke MN. Capillary malformations［J］. Dermatol Clin, 2022,40（4）:425⁃433. doi: 10.1016/j.det.2022. 06.005.
［2］	刘莲, 张自晖, 郝丹, 等. 鲜红斑痣的发病机制研究进展［J］. 中国麻风皮肤病杂志, 2019,35（4）:253⁃256.
［3］	Brightman LA, Geronemus RG, Reddy KK. Laser treatment of port⁃wine stains［J］. Clin Cosmet Investig Dermatol, 2015,8:27⁃33. doi: 10.2147/CCID.S53118.
［4］	Orten SS, Waner M, Flock S, et al. Port⁃wine stains. An assessment of 5 years of treatment［J］. Arch Otolaryngol Head Neck Surg, 1996,122（11）:1174⁃1179. doi: 10.1001/archotol. 1996.01890230022005.
［5］	Michel S, Landthaler M, Hohenleutner U. Recurrence of port⁃wine stains after treatment with the flashlamp⁃pumped pulsed dye laser［J］. Br J Dermatol, 2000,143（6）:1230⁃1234. doi: 10. 1046/j.1365⁃2133.2000.03893.x.
［6］	Kang J, Liu JJ, Fang YH, et al. Hemoporfin⁃mediated photodynamic therapy for port⁃wine stains on extremities［J］. Dermatol Ther （Heidelb）, 2023,13（8）:1857⁃1871. doi: 10.1007/s13555⁃023⁃00970⁃8.
［7］	Sun J, Zhang Y, Ma T, et al. Efficacy of hemoporfin⁃PDT on port⁃wine stains: a retrospective analysis of 2952 cases［J］. Photodiagnosis Photodyn Ther, 2023,44:103837. doi: 10.1016/j.pdpdt.2023.103837.
［8］	Peng X, Ye T, Yu B, et al. Comparing HMME⁃PDT and Cynergy dual⁃wavelength laser in the treatment of facial PWS［J］. Photodiagnosis Photodyn Ther, 2022,37:102703. doi: 10.1016/j.pdpdt.2021.102703.
［9］	Kunimoto K, Yamamoto Y, Jinnin M. ISSVA classification of vascular anomalies and molecular biology［J］. Int J Mol Sci, 2022,23（4）:2358. doi: 10.3390/ijms23042358.
［10］	阚云珍, 缑向楠, 赵跃武, 等. 葡萄酒色斑和Sturge⁃Weber综合征的临床病理及分子遗传学特征［J］. 中华病理学杂志, 2021,50（7）: 802⁃804. doi: 10.3760cma.j.cn112151⁃20210425⁃00316.
［11］	Xu MN, Wang Q, Wang M, et al. Enhanced activation of mTOR signaling pathway was found in the hypertrophic and nodular lesions of port wine stains［J］. Clin Cosmet Investig Dermatol, 2022,15:643⁃651. doi: 10.2147/CCID.S358612.
［12］	李勤, 彭丽霞, 苑凯华, 等. 光动力疗法对鲜红斑痣血管组织学的影响探讨［J］. 广东医学, 2010,31（7）:852⁃854. doi: 10. 3969/j.issn.1001⁃9448.2010.07.020.
［13］	Liu L, Zhou L, Zhao Q, et al. Histological analysis of different types of port⁃wine stains to guide clinical decision making: a retrospective study［J］. Indian J Dermatol Venereol Leprol, 2023,89（2）:204⁃212. doi: 10.25259/IJDVL_730_2021.
［14］	Fölster⁃Holst R, Shukla R, Kassir M, et al. Treatment update of port⁃wine stain: a narrative review［J］. J Drugs Dermatol, 2021,20（5）:515⁃518. doi: 10.36849/JDD.5005.
［15］	Tan W, Zakka LR, Gao L, et al. Pathological alterations involve the entire skin physiological milieu in infantile and early⁃childhood port⁃wine stain［J］. Br J Dermatol, 2017,177（1）:293⁃296. doi: 10.1111/bjd.15068.
［16］	Geronemus RG, Ashinoff R. The medical necessity of evaluation and treatment of port⁃wine stains［J］. J Dermatol Surg Oncol, 1991,17（1）:76⁃79. doi: 10.1111/j.1524⁃4725.1991.tb01597.x.
［17］	Chen D, Hu XJ, Lin XX, et al. Nodules arising within port⁃wine stains: a clinicopathologic study of 31 cases［J］. Am J Dermatopathol, 2011,33（2）:144⁃151. doi: 10.1097/DAD.0b013e3181e169f5.
［18］	Gao L, Yin R, Wang H, et al. Ultrastructural characterization of hyperactive endothelial cells, pericytes and fibroblasts in hypertrophic and nodular port⁃wine stain lesions［J］. Br J Dermatol, 2017,177（4）:e105⁃e108. doi: 10.1111/bjd.15373.
［19］	Burrows PE. Angioarchitecture of hereditary arteriovenous malformations［J］. Semin Intervent Radiol, 2017,34（3）:250⁃257. doi: 10.1055/s⁃0037⁃1604298.
［20］	Delagrange L, Dupuis O, Fargeton AE, et al. Obstetrical and neonatal complications in hereditary haemorrhagic telangiectasia: a retrospective study［J］. BJOG, 2023,130（3）:303⁃311. doi: 10. 1111/1471⁃0528.17303.
［21］	Eerola I, Boon LM, Watanabe S, et al. Locus for susceptibility for familial capillary malformation （'port⁃wine stain'） maps to 5q［J］. Eur J Hum Genet, 2002,10（6）:375⁃380. doi: 10.1038/sj.ejhg.5200817.
［22］	Troilius Rubin A, Lauritzen E, Ljunggren B, et al. Heredity of port⁃wine stains: investigation of families without a RASA1 mutation［J］. J Cosmet Laser Ther, 2015,17（4）:204⁃208. doi: 10.3109/14764172.2015.1007060.
［23］	Shirley MD, Tang H, Gallione CJ, et al. Sturge⁃Weber syndrome and port⁃wine stains caused by somatic mutation in GNAQ［J］. N Engl J Med, 2013,368（21）:1971⁃1979. doi: 10.1056/NEJMoa 1213507.
［24］	Lee KT, Park JE, Eom Y, et al. Phenotypic association of presence of a somatic GNAQ mutation with port⁃wine stain distribution in capillary malformation［J］. Head Neck, 2019,41（12）:4143⁃4150. doi: 10.1002/hed.25962.
［25］	Lian CG, Sholl LM, Zakka LR, et al. Novel genetic mutations in a sporadic port⁃wine stain［J］. JAMA Dermatol, 2014,150（12）:1336⁃1340. doi: 10.1001/jamadermatol.2014.1244.
［26］	Huang L, Bichsel C, Norris AL, et al. Endothelial GNAQ p.R183Q increases ANGPT2 （Angiopoietin⁃2） and drives formation of enlarged blood vessels［J］. Arterioscler Thromb Vasc Biol, 2022,42（1）:e27⁃e43. doi: 10.1161/ATVBAHA.121.316651.
［27］	Öztürk Durmaz E, Demircioğlu D, Yalınay Dikmen P, et al. A review on cutaneous and musculoskeletal manifestations of CLOVES syndrome［J］. Clin Cosmet Investig Dermatol, 2022,15:621⁃630. doi: 10.2147/CCID.S351637.
［28］	Canaud G, Hammill AM, Adams D, et al. A review of mechanisms of disease across PIK3CA⁃related disorders with vascular manifestations［J］. Orphanet J Rare Dis, 2021,16（1）:306. doi: 10.1186/s13023⁃021⁃01929⁃8.
［29］	Chen K, Hu YY, Wang LL, et al. Whole⁃genome sequencing identified KCNJ12 and SLC25A5 mutations in port⁃wine stains［J］. Front Med （Lausanne）, 2022,9:905902. doi: 10.3389/fmed. 2022.905902.
［30］	Baqai U, Kurimchak AM, Trachtenberg IV, et al. Kinome profiling identifies MARK3 and STK10 as potential therapeutic targets in uveal melanoma［J］. J Biol Chem, 2023,299（12）:105418. doi: 10.1016/j.jbc.2023.105418.
［31］	Yue J, López JM. Understanding MAPK signaling pathways in apoptosis［J］. Int J Mol Sci, 2020,21（7）:2346. doi: 10.3390/ijms 21072346.
［32］	Tursch A, Holstein TW. From injury to patterning⁃MAPKs and Wnt signaling in Hydra［J］. Curr Top Dev Biol, 2023,153:381⁃417. doi: 10.1016/bs.ctdb.2023.01.003.
［33］	Bonni A, Brunet A, West AE, et al. Cell survival promoted by the Ras⁃MAPK signaling pathway by transcription⁃dependent and ⁃independent mechanisms［J］. Science, 1999,286（5443）:1358⁃1362. doi: 10.1126/science.286.5443.1358.
［34］	迪丽努尔·吾甫尔, 丁媛, 康晓静. 鲜红斑痣相关基因及激酶的研究进展［J］. 医学综述, 2022,28（6）:1085⁃1090. doi: 10. 3969/j.issn.1006⁃2084.2022.06.009.
［35］	Vindis C, Cerretti DP, Daniel TO, et al. EphB1 recruits c⁃Src and p52Shc to activate MAPK/ERK and promote chemotaxis［J］. J Cell Biol, 2003,162（4）:661⁃671. doi: 10.1083/jcb.200302073.
［36］	Zhao Y, Dong J, Liao Y, et al. Identification and validation of four photodynamic therapy related genes inhibiting MAPK and inducing cell cycle alteration in squamous cell carcinoma［J］. Front Oncol, 2022,12:946493. doi: 10.3389/fonc.2022.946493.
［37］	Garcia⁃Lezana T, Lopez⁃Canovas JL, Villanueva A. Signaling pathways in hepatocellular carcinoma［J］. Adv Cancer Res, 2021,149:63⁃101. doi: 10.1016/bs.acr.2020.10.002.
［38］	Tan W, Chernova M, Gao L, et al. Sustained activation of c⁃Jun N⁃terminal and extracellular signal⁃regulated kinases in port⁃wine stain blood vessels［J］. J Am Acad Dermatol, 2014,71（5）:964⁃968. doi: 10.1016/j.jaad.2014.07.025.
［39］	Yin R, Gao L, Tan W, et al. Activation of PKCα and PI3K kinases in hypertrophic and nodular port wine stain lesions［J］. Am J Dermatopathol, 2017,39（10）:747⁃752. doi: 10.1097/DAD. 0000000000000785.
［40］	Smoller BR, Rosen S. Port⁃wine stains. A disease of altered neural modulation of blood vessels?［J］. Arch Dermatol, 1986,122（2）:177⁃179. doi: 10.1001/archderm.122.2.177.
［41］	Poliner A, Fernandez Faith E, Blieden L, et al. Port⁃wine birthmarks: update on diagnosis, risk assessment for Sturge⁃Weber syndrome, and management［J］. Pediatr Rev, 2022,43（9）:507⁃516. doi: 10.1542/pir.2021⁃005437.
［42］	Finley JL, Noe JM, Arndt KA, et al. Port⁃wine stains. Morphologic variations and developmental lesions［J］. Arch Dermatol, 1984,120（11）:1453⁃1455. doi: 10.1001/archderm.120. 11.1453.
［43］	Rydh M, Malm M, Jernbeck J, et al. Ectatic blood vessels in port⁃wine stains lack innervation: possible role in pathogenesis［J］. Plast Reconstr Surg, 1991,87（3）:419⁃422. doi: 10.1097/00006534⁃ 199103000⁃00003.

[1]	Yang Aimin, Cheng Jiangwei, Huang Jiacheng, Cen Ying, Chen Junjie. Treatment of Merkel cell carcinoma [J]. Chinese Journal of Dermatology, 2024, 57(7): 665-667.
[2]	Liu Qingfeng, Liu Lian, Diao Ping, Li Xiaoxue, Zhang Ting, Chen Haotian, Liu Xu, Jiang Xian. Diagnosis and treatment of port-wine stains-associated syndromes [J]. Chinese Journal of Dermatology, 2024, 57(7): 656-660.
[3]	Diao Ping, Han Chenglong, Liu Lian, Zhou Hui, Li Erlong, Jiang Xian. Efficacy and influencing factors of hematoporphyrin monomethyl ether-mediated photodynamic therapy in the treatment of adult patients with port-wine stains: a retrospective study [J]. Chinese Journal of Dermatology, 2024, 57(7): 595-600.
[4]	Zhang Ting, Liu Lian, Chen Haotian, Wei Danfeng, Liu Xu, Diao Ping, Liu Qingfeng, Jiang Xian. Efficacy of 595-nm pulsed dye laser in the treatment of port‐wine stains in 155 infants and toddlers: a retrospective analysis [J]. Chinese Journal of Dermatology, 2024, 57(7): 610-615.
[5]	Zhang Sheng, Wang Xiuwei, Chen Jianyou, Deng Wei, Zhang Haihua, Zhang Gaolei, Liu Xiaoyan, Su Wei. Efficacy of hematoporphyrin monomethyl ether-mediated photodynamic therapy in the treatment of facial port-wine stains in 15 children with Sturge-Weber syndrome [J]. Chinese Journal of Dermatology, 2024, 57(7): 616-622.
[6]	Jiang Xian, Liu Lian, Zhang Ting. Treatment of port-wine stains: current status and prospects [J]. Chinese Journal of Dermatology, 2024, 57(7): 590-594.
[7]	The Consensus Development Expert Group of Hematoporphyrin Monomethyl Ether-mediated Photodynamic Therapy for Treating Port-wine Stains. Expert consensus on hematoporphyrin monomethyl ether-mediated photodynamic therapy for treating port-wine stains （2024） [J]. Chinese Journal of Dermatology, 2024, 57(7): 581-589.
[8]	Feng Mengdi, Wang Wenqing. Regulatory roles of transcription factors and receptors in the pathogenesis of acne [J]. Chinese Journal of Dermatology, 2024, 57(6): 575-578.
[9]	Sui Changlin, Chang Xiao, Zhao Qi, Zhu Wei. Psoriasis induced by anti-tumor targeted therapy and immunotherapy [J]. Chinese Journal of Dermatology, 2024, 57(6): 570-574.
[10]	Wang Chen, Xue Chenhong, Song Jinghui, Li Jianguo, Li Zhenlu, Zhang Shoumin, Li Ming, Wang Jianbo. Adalimumab for the treatment of three cases of Blau syndrome in a pedigree [J]. Chinese Journal of Dermatology, 2024, 57(6): 553-556.
[11]	Mycobacteriosis Research Group, China “Belt and Road” Dermatology Alliance, Division of Dermatology and STI Diagnosis, Chinese Association on Leprosy. Expert consensus on the clinical diagnosis and treatment of cutaneous tuberculosis in China （2024） [J]. Chinese Journal of Dermatology, 2024, 57(5): 426-434.
[12]	Yan Rufan, Liao Jieyue, Guo Ziyu, Yao Nan, Zhou Wenyu, Luo Shuaihantian, Zhang Guiying, Zhao Ming. Pathogenesis and targeted therapy of pemphigus [J]. Chinese Journal of Dermatology, 2024, 57(4): 374-378.
[13]	Ge Xinhong, Ma Yingdong, Jiao Yaning, Liu Lingling, Zhou Mei, Zi Wei, Li Bowen. Analysis of efficacy and safety of 532-nm picosecond laser in the treatment of early-stage facial seborrheic keratosis [J]. Chinese Journal of Dermatology, 2024, 57(4): 359-362.
[14]	Yue Shuzhen, Shu Ye, Luo Yangyang, Li Keyao, Zhang Yuanyuan, Tang Jianping, Wei Zhu. Efficacy and safety of omalizumab in the treatment of chronic urticaria in children: a retrospective study [J]. Chinese Journal of Dermatology, 2024, 57(4): 354-358.
[15]	Liu Yi, Qu Ying, Lei Wenzhi, Liu Xiaogang, Pan Weihua, Zhang Chao. Clinical efficacy of salt-packing therapy in the treatment of pyogenic granuloma [J]. Chinese Journal of Dermatology, 2024, 0(4): 20230553-e20230553.

Port-wine stains: mechanisms underlying the development and progression

PDF

Knowledge

Abstract

Cite this article

share this article

References ［43］

Related Articles 15

Metrics

Comments

Recommended 10